Law360, New York (February 18, 2011, 12:29 PM ET) -- Last year, China surpassed Japan as the world’s second-largest economy. China’s huge population and explosive growth offer great opportunities for the pharmaceutical industry. According to a recent IMS Health report, China leads a group of 17 so-called “pharmerging” countries, which some predicted would represent $90 billion of increased pharmaceutical spending during 2009-2013, collectively offering 48 percent of the growth in the market in 2013.
“China is the most significant opportunity of the 17, a market that is ‘in a league of its own,’” observed one health...
Taming The Wild West Of IP Protection
To view the full article, take a free trial now.
